Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:
Schedule
Product: Active Ingredient: Dosage Form: New Zealand Sponsor: Manufacturer:
|
Metaraminol Metaraminol tartrate 19mg/mL equivalent to metaraminol base 10mg/mL Solution for injection Max Health Limited Torbay and South Devon NHS Foundation Trust, Paignton, United Kingdom
|
Product: Active Ingredient: Dosage Form: New Zealand Sponsor: Manufacturer:
|
Omeprazole Infusion 40mg Omeprazole 40mg Powder for infusion Dr Reddy’s New Zealand Limited Sofarimex Industria Quimica e Farmaceutica Lda, Agualva, Portugal
|
Product: Active Ingredient: Dosage Form: New Zealand Sponsor: Manufacturers:
|
Omeprazole Injection 40mg Omeprazole sodium 42.6mg equivalent to omeprazole base 40mg Powder for injection Dr Reddy’s New Zealand Limited Sofarimex Industria Quimica e Farmaceutica Lda, Agualva, Portugal Laboratorios Alcala Farma S.L., Madrid, Spain
|
Product: Active Ingredient: Dosage Form: New Zealand Sponsor: Manufacturer:
|
Sandomigran Pizotifen malate 0.725mg equivalent to Pizotifen 0.5mg Tablet AFT Pharmaceuticals Limited Labiana Pharmaceuticals SL, Barcelona, Spain
|
Dated this 25th day of March 2019.
CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).